The IDH mutation status was not available for all tumor samples in any of the four datasets (available for 512/757; see ‘Molecular subtype’ in Methods), therefore, we used the G-CIMP status as proxy for the IDH mutation status. This evidence concerns the gene IDH1 and neoplasm.